Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Accumulated Depreciation: 2020-2022

  • Cullinan Therapeutics' Accumulated Depreciation fell 41.81% to $135,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $135,000, marking a year-over-year decrease of 41.81%. This contributed to the annual value of $135,000 for FY2022, which is 41.81% down from last year.
  • Per Cullinan Therapeutics' latest filing, its Accumulated Depreciation stood at $135,000 for Q4 2022, which was down 41.81% from $232,000 recorded in Q4 2021.
  • Cullinan Therapeutics' Accumulated Depreciation's 5-year high stood at $232,000 during Q4 2021, with a 5-year trough of $135,000 in Q4 2022.
  • Its 3-year average for Accumulated Depreciation is $182,000, with a median of $179,000 in 2020.
  • In the last 5 years, Cullinan Therapeutics' Accumulated Depreciation climbed by 29.61% in 2021 and then slumped by 41.81% in 2022.
  • Over the past 3 years, Cullinan Therapeutics' Accumulated Depreciation (Quarterly) stood at $179,000 in 2020, then climbed by 29.61% to $232,000 in 2021, then crashed by 41.81% to $135,000 in 2022.
  • Its Accumulated Depreciation stands at $135,000 for Q4 2022, versus $232,000 for Q4 2021 and $179,000 for Q4 2020.